Mosa Meat
Dutch pioneer growing beef from cells, still pre-revenue after a decade of R&D.
On the record
Checkpoint: EU Novel Foods decision on cultivated beef fat, submitted Jan 2025, still pending
The call
Mosa Meat has the science and the patents but not the sales, and the runway now runs out before 2028 unless regulators and a big check both arrive on time.
Mosa Meat grows animal meat from cells in large tanks instead of raising and slaughtering animals. The company has built real technical advantages, like special growth recipes and a large production facility, that would be hard and expensive for competitors like JBS or Tyson to copy from scratch. However, the whole lab-grown meat industry is shrinking (other companies have shut down or pulled back), European countries are turning against it politically, and no country has approved it for sale yet, so the company has no paying customers after ten years and is burning through its money fast enough that survival depends on getting a big investment and regulatory approval before its cash runs out around 2028.
Why
01
AI pressure: None apparent. AI tools speed up media optimization inside the lab but no AI product threatens cultivated meat's market. Could AI do the core job? Unlikely.
02
Bigger players: None apparent. JBS, Tyson, and Cargill are watching, not attacking; a strategic buyout is more likely than a copycat product. Could a giant copy it? Probably.
03
What protects it. Patented serum-free growth media, years of regulatory dossiers, and a 7,340 m2 Maastricht plant that a newcomer can't quickly replicate.
What would change this call
EU Novel Foods ruling on Mosa Meat's cultivated beef fat application, submitted Jan 2025. Approval would unlock the EU market; rejection or delay would confirm regulatory risk is materializing.
Whether Mosa Meat closes its next major financing round before the 2028 runway deadline. A flat or up round from a strategic backer signals confidence; a down bridge round signals distress.
Whether Mosa Meat secures Singapore or other APAC regulatory approval with repeat commercial orders. Would show the company can convert technology into real, repeatable revenue like GOOD Meat has.
Whether Mosa Meat closes its next major financing round before the 2028 runway deadline. A flat or up round from a strategic backer signals confidence; a down bridge round signals distress.
Whether Mosa Meat secures Singapore or other APAC regulatory approval with repeat commercial orders. Would show the company can convert technology into real, repeatable revenue like GOOD Meat has.
Key numbers
- Raised EUR15M Series C-II extension
- 99.999% production cost cut since 2013 burger
- Raised EUR40M in single 2024 round
Named risks
- No regulatory approval for Mosa Meat products exists anywhere globally as of Dec 2025.
- Financial runway extends only to 2028, requiring a new capital raise.
- EU political opposition hardening (Italy 2023 ban, Hungary 2025 ban, France/Austria lobbying against sector).
- Sector-wide peer collapses (Meatable wound down, Believer Meats and Meati scaled back) signal category-wide going-concern risk.
- Publicly reported financial figures (valuation, cumulative funding, headcount) are inconsistent across data providers.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Meatable | gaining on | Dutch cultivated-meat peer wound down operations Dec 2025/Jan 2026, reducing direct rivalry |
| Aleph Farms | contesting | Israeli cultivated-beef peer secured regulatory approval in Israel, contesting category leadership |
| GOOD Meat (Eat Just) | losing to | Singapore-approved and commercially further along than Mosa, which had zero approvals as of Dec 2025 |
| Believer Meats | gaining on | US peer scaled back operations per Dec 2025 reporting |
| JBS, Tyson, Cargill | contesting | Conventional meat incumbents reportedly indifferent, more likely to acquire than build competing tech |
Questions people ask
- Is Mosa Meat profitable in 2026?
- No. Mosa Meat remains pre-revenue as of December 2025, with management describing the company as moving 'toward first meaningful revenues' rather than reporting sales; it has raised roughly a decade of capital without a commercial product launch.
- Has Mosa Meat gotten regulatory approval to sell its cultivated beef?
- Not yet anywhere. Mosa Meat filed its first EU Novel Foods application for cultivated beef fat in January 2025, a Switzerland submission with Bell Switzerland in February 2025, and a UK FSA sandbox filing in May 2025; all remained pending as of December 2025.
- Who owns Mosa Meat?
- Mosa Meat is privately held. Investors include Blue Horizon Ventures, M Ventures, Bell Food Group, Mitsubishi Corporation, Nutreco, PHW Group, Invest-NL, LIOF, and Leonardo DiCaprio; publicly listed Agronomics held about 1.68% fully diluted as of April 2024.
- Could AI replace what Mosa Meat does?
- No. AI can speed up R&D subroutines like cell-line selection and culture-media design per a 2024 peer-reviewed review, but it cannot replace Mosa Meat's patented serum-free growth media, regulatory dossiers, or its 7,340 sq m Maastricht bioreactor facility.
- Who is Mosa Meat's biggest competitor?
- Direct cultivated-beef peers include Aleph Farms (Israel, regulatory approval secured) and formerly Meatable (Dutch, wound down December 2025/January 2026); conventional meat giants like JBS, Tyson and Cargill are largely indifferent, favoring investment over in-house competition.
- How much money has Mosa Meat raised?
- Confirmed rounds include €7.5M Series A (July 2018), $85M Series B (closed February 2021), €40M (April 2024), €15M Series C-II (December 2025), and €875,000 in Invest International development capital (July 2026).
Timeline
- 2026-07-08Received EUR875,000 from Invest International for global expansion
- 2026-05-20Joined Asia-Pacific Society for Cellular Agriculture
- 2025-12-23Raised EUR15M Series C-II, cited 99.999% cost reduction, runway to 2028
- 2025-12Dutch peer Meatable wound down operations
- 2025-05Submitted filing to UK Food Standards Agency regulatory sandbox
- 2025-02Filed Switzerland Novel Foods submission with Bell Switzerland
- 2025-01Filed first EU Novel Foods application for cultivated beef fat
- 2024-04-17Raised EUR40M; Agronomics stake at about 1.68% fully diluted
- 2021-02Series B closed at $85M total
- 2018-07Series A raised EUR7.5M
Revision history
25 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Mosa Meat (2026-06-15)
- Agronomics Limited Announces Mosa Meat Raises EUR 40 Million (2024-04-17)
- Series B funding completed at $85 million
- Mosa Meat Raises $17.6M (2025-12-23)
- Mosa Meat targets global expansion (2026-07-08)
- Mosa Meat 2026 Company Profile
- Mosa Meat secures fresh funding (2025-12-22)
- Management and Employees List
- Scaling beef cultivation to industrial production levels (2022-10-17)
- The Mosa Approach (2025-12-20)
- Press Kit (2025-12-22)
- Mosa Meat Joins APAC-SCA (2026-05-20)